Nonprofit founder and CEO, Craig Martin, notes that the industry will likely see more alternative gene therapy commercialisation models in the future.
Zydus will focus on Nufymco’s commercialisation across the US market. Credit: cameranest/Shutterstock.com. Zydus Lifesciences Global FZE, a subsidiary of Zydus, has entered into an agreement with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback